Health
Researchers urge delaying Pfizer vaccine’s second dose as first highly effective – Reuters
The second dose of Pfizer Inc’s COVID-19 vaccine could be delayed in order to cover all priority groups as the first one is highly protective, two Canada-based…
By Reuters Staff
(Reuters) – The second dose of Pfizer Incs COVID-19 vaccine could be delayed in order to cover all priority groups as the first one is highly protective, two Canada-based researchers said in a letter published in the New England Journal of Medicine.
The vaccine had an efficacy of 92.6% after the first dose, Danuta Skowronski and Gaston De Serres said, based on an analysis of the documents submitted by the drugmaker to the U.S. Food and Drug Administration (FDA).
These findings were…
-
General23 hours agoWondering about winter | The Spectator Australia
-
Noosa News22 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
General21 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash
-
General21 hours agoNo ‘band-aid solution’: sweating coal risky business